Add electrolytes or lemon slices to enhance absorption and flavor
However, platforms with multiple therapy verticals may allocate less specialized resources to peptide-specific monitoring, dosing protocols, and compounding oversight compared to specialists focused solely on GLP-1 optimization
Survodutide Research# Survodutide has two published Phase 2 trials: the obesity trial (Lancet Diabetes & Endocrinology, 2024) showing 18.7% weight loss at 46 weeks, and the MASH trial (NEJM, 2024) showing 62% MASH resolution
Zhao, J., Wang, Q., Tan, A
Our weight loss program in Georgetown, Texas ensures that your prescribed medication is directly delivered to your doorstep
Bone Density: Mouse model studies have also linked IGF-1 signaling to improvements in bone density and skeletal strength, suggesting systemic health benefits beyond just muscular development